Riskpilot← Back to searchSign inGet full accessGK Medicin AB
ABActiveOrg 5592898059Allmogevägen 1Medical specialists activities · NACE 8622Est. 20201 employees
Revenue 2025
SEK 1,8M
+29% vs 2024
EBITDA margin
32.0%
+76% vs 2024
Equity ratio
44.6%
Financial strength
Net profit 2025
SEK 466K
+135% vs 2024
| Revenue | SEK 1,8M | +29% |
| EBITDA | SEK 590K | +76% |
| Net profit | SEK 466K | +135% |
| Total assets | SEK 1,2M | +1% |
| Equity | SEK 514K | -14% |
| Employees | 1 | — |
Legal name
GK Medicin AB
Org number
5592898059
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
14 december 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Det bedrivs i privat regi. Vi förenar hög vetenskaplig klass med våra patienter Vår läkare har bred ortopedisk kompetens och jobbar aktivt med skelett ultraljudsundersökningar, vi utför även ortopediska operationer med lokal bedövning samt dagklinik.
Address
Allmogevägen 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 849 | 1 446 | 1 537 | 1 430 | 1 846 |
| Staff expenses | — | −869 | −998 | −1 074 | −840 |
| EBITDA | 426 | 335 | 243 | 335 | 590 |
| Depreciation & amort. | −4 | −8 | −8 | −8 | −8 |
| EBIT | 422 | 327 | 235 | 327 | 583 |
| Net financials | — | −1 | 0 | 7 | 0 |
| Profit before tax | 422 | 326 | 235 | 254 | 583 |
| Tax | −88 | −69 | −52 | −56 | −117 |
| Net profit | 334 | 257 | 183 | 199 | 466 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 731 | 1 030 | 1 131 | 1 143 | 1 153 |
| Equity | 359 | 617 | 704 | 598 | 514 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 372 | 413 | 426 | 465 | 559 |
| Total debt | 372 | 413 | 426 | 465 | 559 |
EBITDA margin
32.0%
This company
15.8%
Market median
+103% vs market
20212025
Equity ratio
44.6%
This company
38.2%
Market median
+17% vs market
20212025
Return on equity
90.7%
This company
18.4%
Market median
+393% vs market
20212025
Net profit margin
25.3%
This company
8.1%
Market median
+212% vs market
20212025
Asset turnover
1.60×
This company
1.12×
Market median
+43% vs market
20212025
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-12-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GK Medicin AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sara Youssef | Deputy Board Member | 0 companies |
| George Khoury | Board of Directors | 0 companies |